PPT-Influenza (Family Orthomyxoviruses

Type A Type B Type C 150 subtypes Strains Subtypes are serologically distinct Antibodies do not crossneutralize between subtypes Strains are serologically identical Antibodies do crossneutralize between strains. 2009 - 2010. Armed Forces Health Surveillance Center (AFHSC). United States Air Force School of Aerospace Medicine (USAFSAM). Naval Health Research Center (NHRC). DoD Global Influenza Network Partners (GEIS Operations). 1. October 2013. Max Planck Institute Magdeburg. Options for continuous production of . cell culture-derived viral vaccines. MAX-PLANCK-INSTITUT. DYNAMIK KOMPLEXER. TECHNISCHER SYSTEME. MAGDEBURG. Frensing. Originally . presented on Wednesday, October 22, 2014 . Learning Objectives. By the end of the webinar participants will be able to : . Understand the rationale for influenza vaccination as well as the indications and contraindications . Vaccine Program. VRBPAC Meeting. . Robin Robinson, Ph.D. . Director, BARDA. Deputy Assistant Secretary, ASPR. February 29, 2012. 1. Pre-2003 Pandemic Influenza . Vaccine Goal & Strategy . Egg-based Vaccines. Industry Perspective for 2014-15 NH Vaccine Supply. The FDA CBER requested this annual summary of information from influenza vaccine manufacturers supplying the U.S., for purposes of a general presentation to the VRBPAC. This summary has been prepared  from a variety of public sources, and was reviewed by AstraZeneca, bioCSL, GSK, Novartis, Protein Sciences, and Sanofi Pasteur.. Don Milton, MD, . DrPH. University of Maryland. School of Public Health. We don’t know . how influenza is transmitted!. “Our understanding of the transmission of influenza is woefully inadequate,”. Disease Case Studies. Prep Steps. Unit 2: Lesson 2. Lesson Questions. What . steps are involved in viral infection and replication. ?. Why are some kinds of influenza virus more deadly than others. ?. Rakhee Palekar, MD, MPH. PAHO/WHO. Background. Influenza A.  subtype H1, H3, . etc. Influenza B distinct lineages emerged in 1970’s B-Yamagata & B-Victoria co-circulated since 2001. On behalf of Philipp Lambach. Considerations in decision making and planning processes for influenza vaccine introduction. Disease. What is influenza burden costing the society?. Vaccine. Are there other . [Name of Critical Access Hospital]. Do no harm . . . . Stick out your arm!. . Mo. Day, Year. The Pathogen. Influenza, often called “the flu” . Contagious respiratory illness . Symptoms vary . Silent Carriers. Two funded influenza vaccines. Key campaign messages. 2018 promotional campaign . Eligibility. Influenza - the disease. 2018 vaccines and strains. Precautions and contraindications. Influenza and healthcare workers. The influenza virus group consists of three enveloped RNA members of the family Orthomyxoviridae:. influenza A, B, and C. . Influenza A . viruses are further classified into hemagglutinin (H) and neuraminidase. RNA virus. of the family . Orthomyxoviridae. that is responsible for the infectious disease . influenza. (or most commonly referred to as flu) in birds, various mammals (such as pigs) and humans. Typically, influenza is characterized by fever, sore throat, chills and other non-specific symptoms, it is a much more severe disease. It is spread around the world in seasonal epidemics and according to World Health Organization, these annual epidemics result in about three to five million cases of severe illness, and about 250 000 to 500 000 deaths.. viruses. . . Swine influenza virus (SIV) is any strain of the . influenza family of viruses. that is . endemic. in . pigs. .. . As of 2009, the known SIV strains include . influenza C. and the subtypes of .